Granulomatosis with polyangiitis (GPA) in a 76-year old woman presenting with pulmonary nodule and accelerating acute kidney injury
Main Article Content
Abstract
Granulomatosis with polyangiitis (GPA), a form of ANCA-associated vasculitis (AAV), is a rare disease with an often-occult presentation. It is more common in 4th and 5th decades of life but can be seen in all ages.
This case report details a 76-year-old female presenting with abdominal pain, generalized weakness, and malaise, who was found to have pulmonary nodules on chest imaging. Biopsy of the lung nodule showed organizing pneumonia. Initially, antibiotics were used to treat the patient. However, she developed acute renal failure a few days after presentation and found to have positive serum C-ANCA as well as elevated ANCA-PR3 serologies. A subsequent kidney biopsy demonstrated pauci-immune necrotizing and crescentic glomerulonephritis that was consistent with GPA and the patient was started immediately on combination immunosuppressive therapy, plasmapheresis, and hemodialysis.
GPA’s clinical and radiological presentation can mimic other common conditions such as pneumonia, malignancy, bacterial sinusitis, pulmonary tuberculosis, sarcoidosis, and urinary tract infection. Because of this, a high level of suspicion is required for early diagnosis and treatment to alter the high mortality rate in this disease entity. All forms of ANCA-associated vasculitis (AAV) should be in the differential diagnosis for all patients presenting with multiorgan system involvement particularly in individuals with pulmonary and renal manifesations.
Article Details
Copyright (c) 2020 Darwich NS, et al.

This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Clinical Nephrology is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | Open Access by Journal of Clinical Nephrology is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
Permission to read and download | ✓ |
Permission to display in a repository | ✓ |
Permission to translate | ✓ |
Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, et al. Granulomatosis with polyangiitis (Wegener’s): an alternative name for Wegener’s granulomatosis. Arthritis Rheum. 2011; 63: 863-864. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21374588
Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitis. Am J Med. 2004; 117: 39-50. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15210387
Gomez-Puerta JA, Hernandez-Rodriguez J, Lopez-Soto A, Bosch X. Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease. Chest 2009; 136: 1101-1111. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19809051
Jayne D. The diagnosis of vasculitis. Best Pract Res Clin Rheumatol.. 2009; 23: 445-453. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19508950
Sedighi S, Aghaie M, Mozafari N, Roshandel G. Different features in Wegener’s Granulomatosis: report of five cases. Journal of Clinical and Diagnostic Research. 2011(Suppl-2), 5:1437-1439.
Specks U, Merkel PA, Seo P, Spiera R, Langford CA, et al. Efficacy of remission-induction regimens for ANCA- associated vasculitis. N Eng J Med. 2013; 369: 417-427. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23902481
Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, et al. Randomized trial of plasma exchange or High-dose methylprednisolone A adjunctive therapy for sever renal vasculitis. J Am Soc Nephrol. 2007; 18: 2180-218. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17582159
Langford CA, Hoffman GS. Wegener’s granulomatosis. Thorax 1999; 54: 629-637. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1745525/
Shafiei K, Luther E, Archie M, Gulick J, Fowler MR. Wegener’s granulomatosis: Case report and brief literature review. J Am Board Fam Pract. 2003; 16: 555-559. PubMed:
Sfiniadaki E, Tsiara I, Theodossiadis P, Chatziralli I. Ocular manifestations of Granulomatosis polyangiitis: A review of the Literature. Ophthalmol Ther (2019) 8:227-234. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14963084
Stewart C, Cohen D, Bhattacharyya I, Scheitler L, Riley S, et al. Oral manifestations of Wegener’s granulomatosis: a report of three cases and literature review. J Am Dent Assoc. 2007; 138: 338-348. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17332039
Storesund B, Gran JT, Koldingsnes W. Severe intestinal involvement in wegener’s granulomatosis: report of two cases and review of the literature. Br J Rheumatol. 1998; 37: 387-390. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9619888
Pagnoux C, Mahr A, Cohen P, Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitidies: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore). 2005; 84: 115128. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15758841
Miller PG, Santini C, Freed MJ. Dysphagia in a patient with Wegener's Granulomatosis: a Case report. Dysphagia. 2001; 16: 136-139. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11305224
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, et al. 2012 revised international chapel Hill onsensus conference Nomenclature of vasculitides. Arthritis Rheum. 2013; 65: 1-11. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23045170
Roth AJ, Ooi JD, Hess JJ, van Timmeren MM, Berg EA, et al. Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest. 2013; 123: 1773-1783. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23549081
Schnabel A, Holl-Ulrich K, Dalhoff K, Reuter M, Gross WL. Efficacy of transbronchial biopsy in pulmonary vasculitidies. Eur Respir J. 1997; 10: 2738-2743. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9493653
Rovin BH, Caster DJ, Cattran DC, Gibson KL, Hogan JJ, et al. Management and treatment of glomerular Diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2019; 95: 281-295; PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30665569
Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, et al. EULAR/ERA-EDTA recommendations for the Management of ANCA-associated vasculitis. Ann Rheum Dis 2016; 75: 1583-1594. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27338776
Tesar V, Rihova Z, Jancova E, Rysava R, Merta M, et al. Current treatment strategies in ANCA-positive renal vasculitis: lessons from European randomized trials. Nephrol Dial Transplant. 2003; 18: Suppl 5: V2-V4. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12817056
Charles P, Néel A, Tieulié N, Hot A, Pugnet G, et al. Rituximab for induction and maintenance treatment of ANCA-Associated vasculitides: a multicenter retrospective study on 80 patients. Rheumatology. 2014; 53: 532-539. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24282319
Getha D, Kallenberg C, Stone JH, Salama AD, Appel GB, et al. Current therapy of Granulomatosis with polyangiitis and microscopic Polyangiitis: the role of rituximab. J Nephrol. 2015; 28: 17-27. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25185728
Merkel PA, Kaplan AA, Falk RJ, Granulomatosis with polyangiitis and microscopic Polyangiitis: intial immunosuppressive therapy. UpToDate. 2020; 1-37.
Jones RB, Furuta S, Tervaert JW. Rituximab versus cyclophosphamide in ANCA-Associated renal vasculitis: 2-year results of a randomized trial. Ann Rheum Dis. 2015; 74: 1178-1182. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25739829
Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, et al. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. American Journal of Kidney Diseases 2003; 42: 1149-1153. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14655185
Walsh M, Merkel PA, Jayne. The Effects of Plasma Exchange and reduced-Dose Glucocorticoids during Remission-Induction for Treatment of Sever ANCA-Associated Vasculitis [abstract]. Arthritis Rheumatol. 2018: 70 (Suppl 10). https://acrabstracts.org/abstract/the-effects-of-plasma-exchange-and-reduced-dose-glucocorticoids-during-remission-induction-for-treatement-of-sever-anca-associated-vasculitis/
Hogan SL, Folk RJ, Chin H, Cai J, Jennette CE, et al. Predictors of relapse and treatment resistance in Antineurtophil Cytoplasmic Antibody-Associated Small-vessel Vasculitis. Ann Intern Med. 2005; 143: 621-631. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16263884
Popa ER, Trevaert JW. The relation between Staphylococcus aureus and Wegener’s Granulomatosis: Current knowledge and future Directions. Intern Med. 2003; 42: 771-780. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14518661
Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-Sulfamethoxazole(CO-TRIMOXAZOLE) for the prevention of relapses of Wegener’s granulomatosis. For the Dutch Co-Trimoxazole Wegener Study group. N Engl J Med. 1996; 335: 16-20. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8637536
Geetha D, Jefferson JA. ANCA-Associated Vasculitis: Core Curriculum 2020. Am J Kidney Dis. 2020; 75: 124-137. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31358311
Jayne DRW, Bruchfeld AN, Harper L, Schaier M, Venning MC, et al. CLEAR study Group. Randomized trial of C5a Receptor inhibitor Avocopan in ANCA-Associated Vasculitis. J AM Soc nephrol. 2017; 28: 2756-2767. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28400446
Salvadori M, Tsalouchos A. Antineutrophil cytoplasmic antibody associated Vasculitides with renal involvement: Open challenges in the remission induction Therapy. World J nephrol. 2018; 7: 71-83. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29736379